AMCP Submits Comments to CMS on Medicare Advantage and Medicare Part D Proposed Rule

The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Medicare & Medicaid Services for the opportunity to provide comments in response to the proposed rule “Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program [CMS-4182-P]” published in the Federal Register on November 28, 2017. AMCP commends CMS for considering how the Medicare Advantage and Part D prescription drug programs can be transformed through innovation to best meet the individual health needs of Medicare beneficiaries.

View More

Related